RxDoctor Payments Data

Fara Nadal, MD

Family Medicine · Jacksonville, FLNPI 1659343796

Payments from drug & device makers

$10,908in general payments, 2019–2025

Across 663 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Amgen$1K
  • AbbVie$1K
  • AstraZeneca$1K
  • Lilly USA, LLC$987
  • Boehringer Ingelheim$701
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$10,68298%
  • Education$2252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,908 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$132,551
Medicare patients
378
Services billed
2,176

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rebif RebidoseInterferon Beta-1a/Albumin12$124,756
MounjaroTirzepatide88$96,523
OzempicSemaglutide68$84,943
JardianceEmpagliflozin53$64,450
XareltoRivaroxaban75$57,848
FarxigaDapagliflozin Propanediol52$54,369
ProliaDenosumab19$33,352
Tresiba Flextouch U-200Insulin Degludec46$27,171
JanuviaSitagliptin Phosphate19$26,239
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$24,127
TrulicityDulaglutide17$23,818
EliquisApixaban25$23,300
VraylarCariprazine Hcl14$22,964
LinzessLinaclotide24$14,880
Synjardy XrEmpagliflozin/Metformin Hcl19$11,203

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$987$120,341105 claims
Novo NordiskOzempic$1,645$84,94368 claims
Boehringer IngelheimJardiance, Synjardy Xr$701$75,65372 claims
Johnson & JohnsonXarelto$118$57,84875 claims
AstraZenecaFarxiga$1,034$54,36952 claims
AbbVieVraylar, Linzess, Synthroid$1,092$41,25887 claims
GSKTrelegy Ellipta, Breo Ellipta$422$34,48351 claims
AmgenProlia$1,268$33,35219 claims
MerckJanuvia, Belsomra$73$32,89434 claims
PfizerEliquis$319$23,30025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Jacksonville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →